Clinical Trial Update: Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP) [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation trial evaluating safety and tolerability of multiple infusions of BPS804 in adults with hypophosphatasia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• BPS804

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Hypophosphatasia | Phase 2 | Status: COMPLETED